-
Je něco špatně v tomto záznamu ?
The miR-29 family in hematological malignancies
B. Fiserova, L. Kubiczkova, L. Sedlarikova, R. Hajek, S. Sevcikova
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
Grantová podpora
NT12130
MZ0
CEP - Centrální evidence projektů
NT14575
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Plný text - Článek
Zdroj
Zdroj
NLK
Directory of Open Access Journals
od 2001
Free Medical Journals
od 1998
Medline Complete (EBSCOhost)
od 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
od 2001
PubMed
25004911
DOI
10.5507/bp.2014.037
Knihovny.cz E-zdroje
- MeSH
- apoptóza genetika MeSH
- extracelulární matrix genetika MeSH
- hematologické nádory genetika MeSH
- lidé MeSH
- mikro RNA genetika fyziologie MeSH
- nádorová transformace buněk genetika MeSH
- proliferace buněk genetika MeSH
- stárnutí buněk genetika MeSH
- tumor supresorové geny fyziologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
BACKGROUND: MicroRNAs are short non-coding regulators of gene expression. The human miR-29 family consists of three members: miR-29a, miR-29b and miR-29c. Members of this family were found to be aberrantly expressed in various types of tumors, including hematological malignancies. This family was described to have both oncogenic and tumor suppressor features influencing various pathological processes, such as tumor growth and apoptosis. This review summarizes current knowledge about the miR-29 family in selected hematological malignancies. CONCLUSION: Recent research of miR-29 family in hematological malignancies has proven its oncogenic as well as tumor suppressive potential. Nevertheless, the level of current evidence is not sufficient, and data remain inconclusive.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17006074
- 003
- CZ-PrNML
- 005
- 20200219094214.0
- 007
- ta
- 008
- 170210s2015 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2014.037 $2 doi
- 035 __
- $a (PubMed)25004911
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Fišerová, Barbora $u Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 245 14
- $a The miR-29 family in hematological malignancies / $c B. Fiserova, L. Kubiczkova, L. Sedlarikova, R. Hajek, S. Sevcikova
- 520 9_
- $a BACKGROUND: MicroRNAs are short non-coding regulators of gene expression. The human miR-29 family consists of three members: miR-29a, miR-29b and miR-29c. Members of this family were found to be aberrantly expressed in various types of tumors, including hematological malignancies. This family was described to have both oncogenic and tumor suppressor features influencing various pathological processes, such as tumor growth and apoptosis. This review summarizes current knowledge about the miR-29 family in selected hematological malignancies. CONCLUSION: Recent research of miR-29 family in hematological malignancies has proven its oncogenic as well as tumor suppressive potential. Nevertheless, the level of current evidence is not sufficient, and data remain inconclusive.
- 650 _2
- $a apoptóza $x genetika $7 D017209
- 650 _2
- $a stárnutí buněk $x genetika $7 D016922
- 650 _2
- $a proliferace buněk $x genetika $7 D049109
- 650 _2
- $a nádorová transformace buněk $x genetika $7 D002471
- 650 _2
- $a extracelulární matrix $x genetika $7 D005109
- 650 _2
- $a tumor supresorové geny $x fyziologie $7 D016147
- 650 _2
- $a hematologické nádory $x genetika $7 D019337
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mikro RNA $x genetika $x fyziologie $7 D035683
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Bešše, Lenka $u Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Clinical Hematology, University Hospital Brno $7 mub2014851432
- 700 1_
- $a Sedlaříková, Lenka $u Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Clinical Hematology, University Hospital Brno $7 xx0214571
- 700 1_
- $a Hájek, Roman, $u Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Clinical Hematology, University Hospital Brno $d 1964- $7 nlk20000083645
- 700 1_
- $a Ševčíková, Sabina, $d 1972- $u Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Clinical Hematology, University Hospital Brno $7 mub2015859787
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic $x 1213-8118 $g Roč. 159, č. 2 (2015), s. 184-191
- 910 __
- $a ABA008 $b A 1502 $c 958 $y 4 $z 0
- 990 __
- $a 20170210 $b ABA008
- 991 __
- $a 20200219094616 $b ABA008
- 999 __
- $a ok $b bmc $g 1192599 $s 966721
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 159 $c 2 $d 184-191 $e 20140704 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- GRA __
- $a NT12130 $p MZ0
- GRA __
- $a NT14575 $p MZ0
- LZP __
- $b NLK118 $a Pubmed-20170210
